FDA Grants Emergency Authorization For MERS-CoV Test

Altona Diagnostics GmbH has received emergency-use authorization for its Middle East Respiratory Syndrome Coronavirus diagnostic.

FDA has issued an emergency use authorization (EUA) for Alton Diagnostics GmbH’s RealStar MERS-CoV RT-PCR Kit, used to detect Middle East Respiratory Syndrome CoronaVirus, or MERS-CoV.

FDA issued the authorization on the condition that the firm make fact sheets available to health care providers the describe interpreting results from the test; and to patients on understanding...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation